Navigation Links
Amgen To Present Data From Four Phase 2 Studies At Upcoming American Heart Association Scientific Sessions 2012
Date:11/2/2012

THOUSAND OAKS, Calif., Nov. 2, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present data from four Phase 2 trials of AMG 145, an investigational fully human monoclonal antibody directed against PCSK9, a protein that reduces the liver's ability to remove low density lipoprotein cholesterol (LDL-C), or "bad" cholesterol from the blood, at the upcoming American Heart Association (AHA) Scientific Sessions 2012.

Selected abstracts of interest that will be presented at the meeting include:

  • Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD): Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
    Late-Breaking Clinical Trials, Monday, Nov. 05, 10:50 a.m. – 11:00 a.m. (Hall G)

  • Goal Achievement after Utilizing an Anti-PCSK9 in Statin Intolerant Subjects (GAUSS): Results from a Randomized, Double-blind, Placebo controlled Study
    Late-Breaking Clinical Trials, Monday, Nov. 05, 11:00 a.m. – 11:10 a.m.  (Hall G)

  • LAPLACE-TIMI 57 Primary Results
    Clinical Science: Special Reports, Tuesday, Nov. 06, 7:45 a.m. – 7:55 a.m.  (Petree Hall D)

  • Efficacy and Safety of a Fully Human Monoclonal Antibody Against PCSK9 as Monotherapy for Hypercholesterolemia: Results from the MENDEL Study, a Global Phase 2 Trial of AMG 145
    Clinical Science: Special Reports, Tuesday, Nov. 06, 7:55 a.m. – 8:05 a.m.  (Petree Hall D)

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics ha
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015  Legendary actor and director Danny Glover ... campaign designed to educate and encourage patients with neurologic ... Affect (PBA) and to speak with their physician. The ... the ability to cry and laugh on cue and ... by people living with PBA episodes. While ...
(Date:5/1/2015)... -- Semler Scientific, Inc. (Nasdaq: SMLR ), an ... markets products that assist healthcare providers in monitoring patients ... the first quarter ended March 31, 2015. ... continued progress with year over year growth of 44% ... said Doug Murphy-Chutorian , M.D., chief executive officer ...
(Date:5/1/2015)... 2015 Cambrex Corporation (NYSE: CBM ) reports ... Highlights , Sales increased 18% compared ... foreign currency impact, driven by Innovator products and Controlled Substances. ... in the first quarter of 2014. , GAAP Diluted ... first quarter last year and Adjusted Diluted EPS was $0.29 ...
Breaking Medicine Technology:Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11
... ® , Inc., a privately held medical device company ... surgery, today announced the launch of the Concero™ Facet ... Neurological Surgeons (AANS) Annual Meeting, Denver, CO. ... alternative to pedicle screws, intended to stabilize the spine ...
... YORK, April 12, 2011 Reportlinker.com announces that a ... Europe Neurology Devices Market Outlook to ... Europe Neurology Devices Market Outlook to 2017 ... "Europe Neurology Devices Market Outlook to 2017" provides key ...
Cached Medicine Technology:Lanx®, Inc. Announces Launch of Concero™ Facet Screw System for Spinal Fusion 2Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 2Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 3Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 4Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 5Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 6Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 7Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 8Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 9Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 10Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 11Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 12Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 13Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 14Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 15Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 16Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 17
(Date:5/1/2015)... May 01, 2015 Jusuru International has ... the successful repositioning of its flagship nutritional supplement, Liquid ... with a new name, new logo, new packaging, new ... Awards are designed to identify and promote programs that ... , “DSA congratulates Jusuru International for their outstanding ...
(Date:5/1/2015)... RESTON, Va. (PRWEB) May 01, 2015 ... the nation’s leading nonprofit authority on the use of ... served as a key contributing resource to the United ... the use of electronically readable cards in Medicare. The ... Beneficiaries and Providers ” was released to the public ...
(Date:5/1/2015)... DC (PRWEB) May 01, 2015 It’s raining ... and House introducing proposals to expand federal support for telemedicine. ... years that ATA has been working with Congress,” said Jonathan ... actions signify how the nation is poised to embrace the ... is one more step in fulfilling ATA’s mission to improve ...
(Date:5/1/2015)... May 01, 2015 Ernst & Young ... Joshua Rosenthal, Co-Founder & CSO, and Burak Sezen, Co-Founder ... the EY Entrepreneur Of The Year® 2015 Awards ... Young is a global leader in assurance, tax, ... be one of the top audit companies in the ...
(Date:5/1/2015)... The Quail Creek Relay for Life Team ... 2001, the Quail Creek Relay team has raised almost $860,000. ... the year, including their biggest event, January’s Dinner and Auction; ... , Quail Creek Relay for Life team was established to ... fitness director, states, “I was hooked when I learned how ...
Breaking Medicine News(10 mins):Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2
... of individuals who suffered from suicidal thoughts and erratic behavior ... ... Mineola, N.Y. (Lexis Nexis) August 5, 2008 - ... personal injury law firm Sanders Viener Grossman LLP, today announced ...
... TRAIT , A new study suggests that people who ... or phenotype that causes them to have poorer asthma ... Researchers from Quebec, Canada compared pulmonary function changes, methacholine ... circumference, and waist-to-hip ratio of 44 obese subjects with ...
... Medicare Regulation Protects, NC Seniors, Access to Quality ... Quality,Nursing Home Care today thanked North Carolina Senators Elizabeth ... bipartisan effort in,Congress to stop the Bush Administration from ... Medicare-funded nursing home care by $5,billion over the next ...
... 4, 2008 - A recent study published in ... (ESAs), a widely used drug to treat anemia, may ... patients. In the study, 323 multiple myeloma patients were ... 1988 to 2007. The investigators reviewed their medical records ...
... 4 Another Eniva nutraceutical moves,to the ... excellent quality and,valid claims. Eniva,s Efacor has ... standards from ConsumerLab.com. ConsumerLab.com,(CL) has long been ... and,quality among nutritional products. CL,s stringent testing ...
... - Total revenue increased 11 percent ... management segment revenue represented 44 percent of total revenue, compared ... - Gross margin rose to 29.4 percent from 28 percent ... share repurchase plan, MINNEAPOLIS, Aug. 4 Health Fitness,Corporation (OTC Bulletin Board: HFIT), a ...
Cached Medicine News:Health News:New York-Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix™ Plaintiffs 2Health News:Chest Journal: August news briefs 2Health News:Dole, Burr Praised for Helping Lead Senate Effort to Stop $21.8 Million North Carolina Medicare Cuts 2Health News:Treatment with anti-anemia drugs may not be safe for multiple myeloma patients 2Health News:Eniva USA Efacor(R) Fish Oil (Non-Fishy Lemon Taste) Receives ConsumerLab.com Seal of Approval 2Health News:HealthFitness Announces 2008 Second Quarter Results 2Health News:HealthFitness Announces 2008 Second Quarter Results 3Health News:HealthFitness Announces 2008 Second Quarter Results 4Health News:HealthFitness Announces 2008 Second Quarter Results 5Health News:HealthFitness Announces 2008 Second Quarter Results 6Health News:HealthFitness Announces 2008 Second Quarter Results 7Health News:HealthFitness Announces 2008 Second Quarter Results 8Health News:HealthFitness Announces 2008 Second Quarter Results 9Health News:HealthFitness Announces 2008 Second Quarter Results 10
... finger into comfortable holder, measuring switch ... measurement is performed., ,Large display ... darker surroundings, back light automatically turns ... weight, compact contour and design provide ...
... Oximeter is a low cost Hand-Held ... A light-weight, highly portable device ... rate measurements, it has easy-to-read red ... batteries, and has a rubber boot ...
... with the sleep environment in mind. ThisQuiet ... and SpO 2 in one affordable ... as well as lab-based sleep studies. This ... pulse oximetry technology for reliable SpO 2 ...
... intraocular lens is a second-generation refractive multifocal ... greater independence from glasses than monofocal IOLs. ... range of vision that monfocals cannot match. ... distributes light over five optic zones so ...
Medicine Products: